ONO-8025 (KRP-197)

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd

Conditions

Overactive Bladder

Phase 2

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

CompletedNCT00212706

Ono Pharmaceutical Co. LtdOveractive Bladder

Start: 2001-10-31Target: 400Updated: 2012-10-12

Phase 3

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

CompletedNCT00212732

Ono Pharmaceutical Co. LtdOveractive Bladder

Start: 2003-10-31Target: 750Updated: 2012-10-11